Trial reportEuropean journal of nutrition2026
A single oral dose of an iso-alpha acids rich hop extract dampens the lipoteichoic acid mediated immune response of monocytes in healthy individuals.
Trial report in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBacterial infections significantly contribute to global mortality. Lipoteichoic acid (LTA), a key component of Gram-positive bacterial cell walls, triggers immune responses via Toll-like receptor 2 (TLR2). Iso-alpha acids (IAA), bitter compounds derived from hops (Humulus lupulus L.), are known for their anti-inflammatory properties, but their effects on human immune modulation remain unclear. This study explored the effect of a single oral dose of IAA on LTA-induced inflammatory responses in human immune cells and underlying molecular mechanisms.
methodsIn a pilot study in healthy female volunteers (n = 5) dose- and time-dependent effects (0-90 mg IAA) on LTA-induced immune responses in monocytes were assessed. A randomized, placebo-controlled cross-over study (n = 13, male and female) evaluated the acute effects of 15 mg IAA. Peripheral blood mononuclear cells (PBMCs) were stimulated with LTA ex vivo, and cytokine release (IL-6, IL-1β) was measured. Mechanistic studies using J774A.1 cells and TLR2-transfected HEK293 cells explored the molecular pathways of IAA.
resultsIn the pilot study, 15 mg IAA was identified as the most tolerated dose in terms of taste for the participants which still had a marked effect on LTA-mediated IL-6 release from monocytes. In the main study, PBMCs from IAA-treated participants showed significantly lower IL-6 and IL-1β secretion after LTA stimulation compared to placebo (p < 0.05). In vitro, IAA suppressed JNK-mediated inflammatory signaling without affecting TLR2 activation.
conclusionA single low-dose intake of IAA from hops reduces LTA-induced cytokine release in blood immune cells, likely via JNK inhibition, suggesting its potential role in modulating inflammatory responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.